COSCIENS Biopharma Inc. Stock
Stocks
CSCI
CA22112H2000
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Toronto S.E.
18:14:51 03/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 7.400 CAD | -1.33% |
|
+1.37% | -13.15% |
| 08-12 | Earnings Flash (CSCI.TO) COSCIENS Biopharma Inc. Reports Q2 Revenue $3.1M | MT |
| 08-12 | COSCIENS Biopharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 5.35M 4.6M 4.33M 3.96M 7.4M 505M 7.42M 51.16M 19.85M 259M 20.08M 19.64M 835M | P/E 2024 |
-0.45x | P/E 2025 | -0.63x |
|---|---|---|---|---|---|
| Enterprise Value | 190K 163K 154K 140K 262K 17.91M 263K 1.81M 704K 9.19M 712K 697K 29.61M | EV / Sales 2024 |
-0.97x | EV / Sales 2025 | 0.19x |
| Free-Float |
72.47% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| CSCI | Delayed | |
OTC Markets
| CSCIF | Delayed | |
Deutsche Boerse AG
| ET80 | Delayed | |
Boerse Muenchen
| ET80 | Real-time | |
Börse Stuttgart
| ET80 | Delayed |
| 1 day | -1.33% | ||
| 1 week | +1.37% | ||
| Current month | +1.37% | ||
| 1 month | +4.96% | ||
| 3 months | -3.65% | ||
| 6 months | +22.72% | ||
| Current year | -13.15% |
| 1 week | 7.25 | 7.5 | |
| 1 month | 7 | 7.95 | |
| Current year | 3.3 | 14.8 | |
| 1 year | 3.3 | 14.8 | |
| 3 years | 3.3 | 45.39 | |
| 5 years | 3.3 | 372 | |
| 10 years | 3.3 | 2,228.99 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/4/26 A | Option | Director | 6,000 | 0.5653% | ||
| 8/4/26 A | Option | Chief Technology Officer | 11,000 | 1.0364% | ||
| 8/4/26 A | Other | Chief Technology Officer | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.33% | +1.37% | -28.50% | -81.97% | 5.33M | ||
| -2.54% | -2.84% | -1.77% | +14.33% | 48.93B | ||
| -0.40% | +1.03% | +418.57% | +527.30% | 45.01B | ||
| -1.42% | +2.30% | +42.67% | +22.37% | 44.07B | ||
| -1.22% | -2.31% | +4.82% | +77.49% | 40.73B | ||
| +0.53% | -1.36% | +16.87% | +46.82% | 33.52B | ||
| -0.21% | +9.14% | - | - | 17.77B | ||
| -0.35% | -1.56% | +21.42% | +120.75% | 16.5B | ||
| -1.01% | +0.50% | +13.91% | +31.83% | 14.67B | ||
| -1.65% | -1.03% | +75.93% | +41.12% | 13.77B | ||
| Average | -0.96% | +0.48% | +62.66% | +88.89% | 27.5B | |
| Weighted average by Cap. | -1.03% | +0.11% | +89.42% | +128.97% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.59M 8.25M 7.76M 7.09M 13.26M 905M 13.3M 91.72M 35.59M 464M 36M 35.21M 1.5B | 7.5M 6.45M 6.07M 5.55M 10.37M 708M 10.4M 71.73M 27.84M 363M 28.16M 27.54M 1.17B |
| Net income | -15.31M -13.17M -12.39M -11.32M -21.18M -1.45B -21.24M -146M -56.83M -742M -57.49M -56.23M -2.39B | -10.36M -8.91M -8.39M -7.66M -14.33M -978M -14.37M -99.09M -38.45M -502M -38.9M -38.05M -1.62B |
| Net Debt | -14.08M -12.12M -11.4M -10.42M -19.48M -1.33B -19.54M -135M -52.28M -682M -52.88M -51.73M -2.2B | -5.16M -4.44M -4.18M -3.81M -7.14M -487M -7.16M -49.35M -19.15M -250M -19.37M -18.95M -805M |
Employees
28
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | CA$7.400 | -1.33% | 1,706 |
| 02/09/26 | CA$7.500 | +3.45% | 100 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CSCI Stock
Select your edition
All financial news and data tailored to specific country editions

















